Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder

Recruiting

Phase 2

Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality DisorderPsilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder

Sponsor:

University of Chicago

Code:

NCT05399498

Conditions

Borderline Personality Disorder

Major Depressive Disorder

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Psilocybin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by University of Chicago on 2025-03-25.